Sino Biopharmaceutical | 1177 - Cash And Equivalent

Stock Price
5.25
Daily Change
-0.14 -2.60%
Monthly
-11.76%
Yearly
29.31%
Q2 Forecast
5.22

Sino Biopharmaceutical reported CNY3.38B in Cash and Equivalent for its fiscal semester ending in December of 2024.





Cash And Equivalent Change Date
Akebia Therapeutics USD 162.64M 22.2M Mar/2026
Alaunos Therapeutics USD 354K 1.03M Mar/2026
Avita Medical AUD 10.24M 1.98M Dec/2025
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
Dianthus Therapeutics USD 627.67M 576.58M Mar/2026
Ionis Pharmaceuticals USD 1.92B 758M Mar/2026
IQVIA Holdings USD 1.95B 33M Mar/2026
Jiangsu Hengrui CNY 40.96B 591.41M Dec/2025
Moderna USD 1.91B 687M Mar/2026
Organon & Co USD 1.12B 542M Mar/2026
Revvity USD 860.32M 59.54M Mar/2026
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Tectonic Therapeutic USD 236.89M 16.9M Mar/2026
Viatris USD 1.8B 481.8M Mar/2026
Xeris Pharmaceuticals USD 111.75M 708K Mar/2026